Jack Silberstein Defends His Thesis!

Congratulations to Jack for defending his thesis entitled “Structural Insights into an Immune Checkpoint Receptor Reveal a Novel Approach to Cancer Immunotherapy”!

Jack is now moving to Cambridge, MA where he is a co-founder of and working at a biotech startup. We will miss his impressive scientific and biotech industry knowledge, but we are so excited to see the great things he does in Cambridge and beyond!